PuSH - Publication Server of Helmholtz Zentrum München: IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Koppe, C.* ; Verheugd, P.* ; Gautheron, J.* ; Reisinger, F. ; Kreggenwinkel, K.* ; Roderburg, C.* ; Quagliata, L.* ; Terracciano, L.* ; Gassler, N.* ; Tolba, R.H.* ; Boege, Y.* ; Weber, A.* ; Karin, M.* ; Luedde, M.* ; Neumann, U.P.* ; Weiskirchen, R.* ; Tacke, F.* ; Vucur, M.* ; Trautwein, C.* ; Lüscher, B.* ; Preisinger, C.* ; Heikenwälder, M.* ; Luedde, T.*

IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1.

Hepatology 64, 1217-1231 (2016)

Publ. Version/Full Text

DOI

PMC

	Free by publisher

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

The IκB-Kinase (IKK) complex - consisting of the catalytic subunits IKKα and IKKβ as well as the regulatory subunit NEMO - mediates activation of the NF-κB pathway, but previous studies suggested the existence of NF-κB-independent functions of IKK subunits with potential impact on liver physiology and disease. Programmed cell-death is a crucial factor in the progression of liver diseases, and Receptor-Interacting-Kinases (RIPKs) exerts strategic control over multiple pathways involved in regulating novel programmed cell-death pathways and inflammation. We hypothesized that RIPKs might be unrecognized targets of the catalytic IKK-complex subunits, thereby regulating hepatocarcinogenesis and cholestasis. In this present study, mice with specific genetic inhibition of catalytic IKK activity in liver parenchymal cells (LPC) (IKKα/β(LPC-KO) ) were intercrossed with RIPK1(LPC-KO) or RIPK3(-/-) mice to examine if RIPK1 or RIPK3 might be downstream targets of IKKs. Moreover, we performed in vivo phospho-proteome analyses and in vitro kinase assays, mass spectrometry and mutagenesis experiments. These analyses revealed that IKKα and IKKβ - in addition to their known function in NF-κB activation - directly phosphorylate RIPK1 at distinct regions of the protein, thereby regulating cell viability. Loss of this IKKα/β-dependent RIPK1-phosphorylation in LPC inhibits compensatory proliferation of hepatocytes and intrahepatic biliary cells, thus impeding HCC development but promoting biliary cell paucity and lethal cholestasis. CONCLUSIONS: Collectively, these findings show that IKK-complex subunits transmits a previously unrecognized signal through RIPK1, which is fundamental for the long term consequences of chronic hepatic inflammation and might have potential implications for future pharmacological strategies against cholestatic liver disease and cancer.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Cholestasis ; Inflammation ; Liver Cancer ; Programmed Cell-death ; Proliferation; Hepatocellular-carcinoma; Ikk-alpha; Programmed Necrosis; Rip1 Kinase; Tnf-alpha; Cancer; Liver; Activation; Apoptosis; Proliferation

ISSN (print) / ISBN 0270-9139

e-ISSN 1527-3350

Journal Hepatology

Quellenangaben Volume: 64, Issue: 4, Pages: 1217-1231

Publisher Wiley

Publishing Place Hoboken, NJ

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Virology (VIRO)